Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by biorunon Jan 25, 2022 8:59am
121 Views
Post# 34357310

RE:Skin Whitening Article on CNN News online tonight

RE:Skin Whitening Article on CNN News online tonightBy the current share price, Sirona is clearly unable to convince shareholders that it is a meaningful player in this market. There is zero doubt in my mind that Sirona has the product tech to address the problem statement here. But that doesn't seem to matter.

The only way is for a reputable partner to come to the table with a deal that speaks commitment and market reach. R&F is clearly a first mover but they got the sweetheart deal of the century from Sirona.

Don't buy now, you might actually make a lot of money (or not, let me be clear on that) and that would be a problem and mess up the narrative here on this board.
<< Previous
Bullboard Posts
Next >>